Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2019 2
2020 1
2021 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Metabolomics in acromegaly: a systematic review.
Pînzariu O, Georgescu CE. Pînzariu O, et al. J Investig Med. 2023 Aug;71(6):634-645. doi: 10.1177/10815589231169452. Epub 2023 May 4. J Investig Med. 2023. PMID: 37139720 Review.
The therapeutic response heterogeneity in acromegaly persists, despite the medical-surgical advances of recent years. ...Choline, the ubiquitous metabolite identified in growth hormone (GH)-secreting pituitary adenomas (Pas) by in vivo magnetic resonance spec …
The therapeutic response heterogeneity in acromegaly persists, despite the medical-surgical advances of recent years. ...Choline, the …
PREDICTIVE MARKERS FOR POSTSURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE.
Ezzat S, Caspar-Bell GM, Chik CL, Denis MC, Domingue MÈ, Imran SA, Johnson MD, Lochnan HA, Grégoire Nyomba BL, Prebtani A, Ridout R, Ramirez JAR, Van Uum S. Ezzat S, et al. Endocr Pract. 2019 Apr;25(4):379-393. doi: 10.4158/EP-2018-0500. Epub 2019 Jan 18. Endocr Pract. 2019. PMID: 30657362
Methods: We carried out a systematic literature review on three of the best studied and most practical predictive markers of the response to somatostatin analogues (SSAs): somatostatin receptor (SSTR) expression, tumor morphologic classification, and T2-weighted magnetic
Methods: We carried out a systematic literature review on three of the best studied and most practical predictive markers of the response to …
Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature.
Ogando-Rivas E, Alalade AF, Boatey J, Schwartz TH. Ogando-Rivas E, et al. Pituitary. 2017 Dec;20(6):702-708. doi: 10.1007/s11102-017-0826-6. Pituitary. 2017. PMID: 28766078 Review.
The relative frequency of each subtype of hormone-secreting adenomas confirmed with magnetic resonance image (MRI), surgery and immunohistochemistry is not defined. ...It is critical to remove all identified possible adenomas to achieve biochemical cure and c …
The relative frequency of each subtype of hormone-secreting adenomas confirmed with magnetic resonance image (MRI), sur …
Primary tumors of the posterior pituitary: A systematic review.
Guerrero-Pérez F, Marengo AP, Vidal N, Iglesias P, Villabona C. Guerrero-Pérez F, et al. Rev Endocr Metab Disord. 2019 Jun;20(2):219-238. doi: 10.1007/s11154-019-09484-1. Rev Endocr Metab Disord. 2019. PMID: 30864049 Review.
Main presentation symptoms were visual disorders (n = 142; 58.1%), headache (n = 99; 40.5%), hypopituitarism (n = 84; 34.4%), hypercortisolism (n = 10; 4.1%), polyuriapolydipsia (n = 6; 2.4%) and acromegaly features (n = 5; 2.0%). On MRI, 122 (47.6%) patients showed …
Main presentation symptoms were visual disorders (n = 142; 58.1%), headache (n = 99; 40.5%), hypopituitarism (n = 84; 34.4%), hypercortisoli …
Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly.
Marques-Pamies M, Gil J, Jordà M, Puig-Domingo M. Marques-Pamies M, et al. Arch Med Res. 2023 Dec;54(8):102924. doi: 10.1016/j.arcmed.2023.102924. Epub 2023 Dec 1. Arch Med Res. 2023. PMID: 38042683
BACKGROUND AND AIMS: Predictors of first-generation somatostatin receptor ligands (fgSRLs) response in acromegaly have been studied for over 30 years, but they are still not recommended in clinical guidelines. ...Most of them are retrospective studies performed between 199 …
BACKGROUND AND AIMS: Predictors of first-generation somatostatin receptor ligands (fgSRLs) response in acromegaly have been studied f …
Multiple Pituitary Adenomas: A Systematic Review.
Budan RM, Georgescu CE. Budan RM, et al. Front Endocrinol (Lausanne). 2016 Feb 1;7:1. doi: 10.3389/fendo.2016.00001. eCollection 2016. Front Endocrinol (Lausanne). 2016. PMID: 26869991 Free PMC article. Review.
Specific challenges associated with MPA include high surgical failure rates, enforcing second-look surgery in certain cases, and difficult preoperative neuroradiological imaging evaluation, with an overall sensitivity of only 25% for magnetic resonance ima
Specific challenges associated with MPA include high surgical failure rates, enforcing second-look surgery in certain cases, and difficult p …
A Chinese Case of X-Linked Acrogigantism and Systematic Review.
Liang H, Gong F, Liu Z, Yang Y, Yao Y, Wang R, Wang L, Chen M, Pan H, Zhu H. Liang H, et al. Neuroendocrinology. 2021;111(12):1164-1175. doi: 10.1159/000512240. Epub 2020 Oct 13. Neuroendocrinology. 2021. PMID: 33049741
Growth hormone (GH) was not suppressed by the glucose-GH inhibition test, and insulin-like growth factor 1 (IGF-1) and prolactin (PRL) levels were elevated. Pituitary MRI revealed a pituitary enlargement with a maximum diameter of 22.3 mm. Octreotide imaging indicat …
Growth hormone (GH) was not suppressed by the glucose-GH inhibition test, and insulin-like growth factor 1 (IGF-1) and prolactin (PRL) level …
Pseudoacromegaly-A challenging entity in the endocrine clinic: A systematic review.
Marques P, Sapinho I, Korbonits M. Marques P, et al. Clin Endocrinol (Oxf). 2024 Mar 28. doi: 10.1111/cen.15053. Online ahead of print. Clin Endocrinol (Oxf). 2024. PMID: 38549284
GH excess was more frequently excluded based on two tests (53%). Magnetic resonance imaging (MRI) was performed in 30 patients, with pituitary adenoma or hyperplasia being reported in eight and three patients, respectively. ...Pachydermoperiostosis and …
GH excess was more frequently excluded based on two tests (53%). Magnetic resonance imaging (MRI) was performed …
Double pituitary adenomas: report of two cases and systematic review of the literature.
Zhang Y, Gong X, Pu J, Liu J, Ye Z, Zhu H, Lu L, Pan H, Deng K, Yao Y. Zhang Y, et al. Front Endocrinol (Lausanne). 2024 Apr 2;15:1373869. doi: 10.3389/fendo.2024.1373869. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38628582 Free PMC article.
The most common endocrine manifestations were Cushing's syndrome (23/59, 38.98%) and acromegaly (20/59, 33.90%). The most prevalent immunohistochemical types were ACTH-immunopositive (31/118, 26.27%) and GH-immunopositive (31/118, 26.27%) tumors. Microadenomas (<1cm) we …
The most common endocrine manifestations were Cushing's syndrome (23/59, 38.98%) and acromegaly (20/59, 33.90%). The most prevalent i …